Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Bridget K. Urie"'
Autor:
Bonnie K Harrington, Heather L Gardner, Raquel Izumi, Ahmed Hamdy, Wayne Rothbaum, Kevin R Coombes, Todd Covey, Allard Kaptein, Michael Gulrajani, Bart Van Lith, Cecile Krejsa, Christopher C Coss, Duncan S Russell, Xiaoli Zhang, Bridget K Urie, Cheryl A London, John C Byrd, Amy J Johnson, William C Kisseberth
Publikováno v:
PLoS ONE, Vol 11, Iss 7, p e0159607 (2016)
Acalabrutinib (ACP-196) is a second-generation inhibitor of Bruton agammaglobulinemia tyrosine kinase (BTK) with increased target selectivity and potency compared to ibrutinib. In this study, we evaluated acalabrutinib in spontaneously occurring cani
Externí odkaz:
https://doaj.org/article/885fb92964b3445a99b5a10f0adb8206
Publikováno v:
Can Vet J
There are limited data on glucocorticoid treatment in dogs. The purpose of this study was to investigate whether dogs of higher body weight experienced more adverse events when receiving glucocorticoid therapy. Data pertaining to glucocorticoid thera
Autor:
Alyson N. Frederick, Whitney D. Hinson, Chad W. Schmiedt, Ada O. Youk, Anthony D. Pardo, Bridget K. Urie
Publikováno v:
Journal of the American Veterinary Medical Association. 256(4)
OBJECTIVE To describe clinical findings and survival times for dogs with functional thyroid tumors treated with surgery alone and investigate potential prognostic factors for outcome in these patients. ANIMALS 27 client-owned dogs. PROCEDURES Medical
Publikováno v:
Journal of the American Veterinary Medical Association. 248:1148-1156
OBJECTIVE To evaluate outcomes for dogs following marginal tumor excision and intralesional placement of cisplatin-impregnated beads for the treatment of cutaneous or subcutaneous soft tissue sarcomas (STSs) and assess local toxic effects of cisplati
Autor:
Bridget K. Urie, Ahmed Hamdy, Wayne Rothbaum, Raquel Izumi, Kevin R. Coombes, Bonnie K. Harrington, Xiaoli Zhang, William C. Kisseberth, Amy J. Johnson, John C. Byrd, Cecile M. Krejsa, Christopher C. Coss, Duncan S. Russell, Heather L. Gardner, Cheryl A. London, Bart Van Lith, Todd Covey, Allard Kaptein, Michael Gulrajani
Publikováno v:
PLoS ONE, Vol 11, Iss 7, p e0159607 (2016)
PLoS ONE
PLoS ONE
Acalabrutinib (ACP-196) is a second-generation inhibitor of Bruton agammaglobulinemia tyrosine kinase (BTK) with increased target selectivity and potency compared to ibrutinib. In this study, we evaluated acalabrutinib in spontaneously occurring cani
Publikováno v:
Journal of the American Veterinary Medical Association. 245(1)
Autor:
Bridget K. Urie, Gregory Almond, Christopher M. Smith, Stephen D. Lenz, Debra M. Beard, Clinton D. Lothrop, D. Michael Tillson, William R. Brawner
Publikováno v:
Journal of the American Veterinary Medical Association. 230(11)
Objective—To determine clinical status and renal and hematopoietic function after kidney donation and identify risks associated with kidney donation in dogs. Design—Prospective study. Animals—14 dogs that underwent unilateral nephrectomy for ki
Publikováno v:
BMC Veterinary Research
BMC Veterinary Research, Vol 8, Iss 1, p 67 (2012)
BMC Veterinary Research, Vol 8, Iss 1, p 67 (2012)
Background Toceranib phosphate (Palladia) has a reported objective response rate of 25% in both canine apocrine gland anal sac adenocarcinoma (AGASACA) and thyroid carcinoma (TC), with stable disease occurring in an additional 50-60% of dogs. The bas